Anatara Lifesciences Ltd has released a press release.
Revised Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Anatara Lifesciences Ltd on 6ix
Story so far
Earlier from Anatara Lifesciences
- Appendix 4C & Q2 FY23 Activities Report
- Completion of Non-renounceable Entitlement Offer and Shortfa
- Appendix 4C & Q1 FY23 Activities Report
- Placement and Entitlement Offer
- Entitlement Offer Prospectus
Later from Anatara Lifesciences
- Placement of Shortfall from Entitlement Offer
- Half Yearly Report and Accounts
- Anatara Company Update
- Appendix 4C & Q3 FY23 Activities Report
- Anatara Update on GaRP Irritable Bowel Syndrome Trial
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences